ROYAL BANK OF CANADA

Bank

Position in GTBP — GT Biopharma, Inc.

CIK 1000275 TORONTO, A6

Position in GTBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$51

+$40 QoQ

Shares Held

126

+2420.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $1,958,380,965 across 412 Biotechnology names. GTBP ranks #375 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,111,871	$496,494,870
2	IONS	Ionis Pharmaceuticals Inc	3,801,815	$285,478,282
3	REGN	Regeneron Pharmaceuticals, Inc.	351,171	$271,328,756
4	ALNY	Alnylam Pharmaceuticals, Inc.	791,515	$261,888,563
5	INCY	Incyte Corp	1,054,123	$99,214,053
6	INSM	INSMED Inc	523,101	$85,537,473
7	MRNA	Moderna, Inc.	999,340	$50,766,470
8	HALO	Halozyme Therapeutics, Inc.	658,290	$42,545,279

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$51	126	+2420.0%	Shares	Defined	2026-05-15
2024-09-30	$11	5	-28.6%	Shares	Defined	2024-11-14
2024-06-30	$19	7	0.0%	Shares	Defined	2024-11-06
2024-03-31	$31	7	-99.7%	Shares	Defined	2024-11-05
2023-12-31	—	2,197	-9.8%	Shares	Defined	2024-02-14
2023-09-30	—	2,436	-36.2%	Shares	Defined	2023-11-14
2023-06-30	—	3,819	+52.3%	Shares	Defined	2023-08-14
2023-03-31	—	2,508	-99.1%	Shares	Defined	2023-05-15
2022-12-31	—	281,958	+13534.3%	Shares	Defined	2023-02-14
2022-09-30	—	2,068	+5.6%	Shares	Defined	2022-11-14
2022-06-30	—	1,958	-35.8%	Shares	Defined	2022-08-15
2022-03-31	—	3,049	-52.2%	Shares	Defined	2022-05-16
2021-12-31	—	6,377	+54.3%	Shares	Defined	2022-02-14
2021-09-30	—	4,134	+15.2%	Shares	Defined	2021-11-15
2021-06-30	—	3,590	-85.4%	Shares	Defined	2021-08-16
2021-03-31	—	24,542	—	Shares	Defined	2021-07-20
No filing history on record for this holder in this stock.